Athersys Inc. Stock
Your prediction
Athersys Inc. Stock
Our community identified positive and negative aspects for Athersys Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Athersys Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.
Pros and Cons of Athersys Inc. in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Athersys Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Athersys Inc. | - | - | - | - | - | - | - |
| Heron Therapeutics Inc. | 0.520% | -14.077% | -20.289% | -58.236% | -23.294% | -57.823% | -94.153% |
| Evolus Inc | 0.000% | 27.778% | 25.683% | -60.000% | -15.596% | -40.645% | -54.747% |
| Sangamo Therapeutics Inc. | 2.190% | 5.951% | 7.909% | -61.436% | 1.801% | -83.348% | -96.276% |
Comments
Athersys, Inc. (NASDAQ: ATHX) is now covered by analysts at Alliance Global Partners. They set a "buy" rating on the stock.
Show more
Ratings data for ATHX provided by MarketBeat
